Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar

BMJ 2003; 327 doi: 10.1136/bmj.327.7410.343-c (Published 7 August 2003)
Cite this as: BMJ 2003;327:343.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter M Lapsley (plapsley@eczema.org), chief executive
  1. Skin Care Campaign, London N19 5NA

    EDITOR—As the British umbrella organisation representing the interests of all people with skin diseases and their patients' groups, the Skin Care Campaign welcomed the balanced approach taken by Herxheimer in his article on the relationship between the pharmaceutical industry and patients' organisations.1 However, we contest the argument that industry will if nothing else influence policy if it directly …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL